The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
Open accessPublished version of a preprint
Abstract
SARS-CoV-2 continues to acquire mutations in the spike receptor-binding domain (RBD) that impact ACE2 receptor binding, folding stability, and antibody recognition. Deep mutational scanning prospectively characterizes the impacts of mutations on these biochemical properties, enabling rapid assessment of new mutations seen during viral surveillance. However, the effects of mutations can change as the virus evolves, requiring updated deep mutational scans. We determined the impacts of all single amino acid mutations in the Omicron BA.1 and BA.2 RBDs on ACE2-binding affinity, RBD folding, and escape from binding by the LY-CoV1404 (bebtelovimab) monoclonal antibody. The effects of some mutations in Omicron RBDs differ from those measured in the ancestral Wuhan-Hu-1 background. These epistatic shifts largely resemble those previously seen in the Alpha variant due to the convergent epistatically modifying N501Y substitution. However, Omicron variants show additional lineage-specific shifts, including examples of the epistatic phenomenon of entrenchment that causes the Q498R and N501Y substitutions present in Omicron to be more favorable in that background than in earlier viral strains. In contrast, the Omicron substitution Q493R exhibits no sign of entrenchment, with the derived state, R493, being as unfavorable for ACE2 binding in Omicron RBDs as in Wuhan-Hu-1. Likely for this reason, the R493Q reversion has occurred in Omicron sub-variants including BA.4/BA.5 and BA.2.75, where the affinity buffer from R493Q reversion may potentiate concurrent antigenic change. Consistent with prior studies, we find that Omicron RBDs have reduced expression, and identify candidate stabilizing mutations that ameliorate this deficit. Last, our maps highlight a broadening of the sites of escape from LY-CoV1404 antibody binding in BA.1 and BA.2 compared to the ancestral Wuhan-Hu-1 background. These BA.1 and BA.2 deep mutational scanning datasets identify shifts in the RBD mutational landscape and inform ongoing efforts in viral surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2022) · Nature · doi:10.1038/s41586-021-04385-3 · Cited by 2,006
Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H. D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.007 · Cited by 1,016
Self-citationProspective mapping of viral mutations that escape antibodies used to treat COVID-19
Starr, T. N., Greaney, A. J., Addetia, A., Hannon, W. W., Choudhary, M. C., Dingens, A. S., Li, J. Z., & Bloom, J. D. (2021) · Science · doi:10.1126/science.abf9302 · Cited by 743
Self-citationStructural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
McCallum, M., Czudnochowski, N., Rosen, L. E., Zepeda, S. K., Bowen, J. E., Walls, A. C., Hauser, K., Joshi, A., Stewart, C., Dillen, J. R., et al. (2022) · Science · doi:10.1126/science.abn8652 · Cited by 535
Self-citationAn engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
Chan, K. K., Tan, T. J. C., Narayanan, K. K., & Procko, E. (2021) · Science Advances · doi:10.1126/sciadv.abf1738 · Cited by 152
Research works printed but not linked: 44
- TN Starr, 2020, Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding., Cell, 182, 1295, 10.1016/j.cell.2020.08.012 · DOI · Paper page
- MC Maher, 2022, Predicting the mutational drivers of future SARS-CoV-2 variants of concern., Sci Transl Med., eabk3445, 10.1126/scitranslmed.abk3445 · DOI · Paper page
- AJ Greaney, 2022, An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain., Virus Evol., 8, veac021, 10.1093/ve/veac021 · DOI · Paper page
- JM Taft, 2022, Deep Mutational Learning Predicts ACE2 Binding and Antibody Escape to Combinatorial Mutations in the SARS-CoV-2 Receptor Binding Domain., Cell, 0
- TN Starr, 2016, Epistasis in protein evolution, Protein Sci, 25, 1204, 10.1002/pro.2897 · DOI · Paper page
- TN Starr, 2022, Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution, Science, 377, 420, 10.1126/science.abo7896 · DOI · Paper page
- R Viana, 2022, Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa, Nature
- H Tegally, 2022, Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa., Nat Med
- P Han, 2022, Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2, Cell, 185, 630, 10.1016/j.cell.2022.01.001 · DOI · Paper page
- E Cameroni, 2022, Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift, Nature, 602, 664, 10.1038/s41586-021-04386-2 · DOI · Paper page
- K Javanmardi, 2022, Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein, Cell Host Microbe
- JE Bowen, 2022, Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines, Science, eabq0203
- DP Martin, 2022, Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function, Mol Biol Evol, 39
- A Moulana, 2022, Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1., bioRxiv, 2022
- J Zahradník, 2021, SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution, Nature Microbiology, 6, 1188, 10.1038/s41564-021-00954-4 · DOI · Paper page
- N Bate, 2022, In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding., PLoS Pathog., 18, e1010733, 10.1371/journal.ppat.1010733 · DOI
- EV Shusta, 1999, Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency, J Mol Biol, 292, 949, 10.1006/jmbi.1999.3130 · DOI · Paper page
- ET Boder, 1997, Yeast surface display for screening combinatorial polypeptide libraries, Nat Biotechnol, 15, 553, 10.1038/nbt0697-553 · DOI · Paper page
- RM Adams, 2016, Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves., Elife, 5, 10.7554/eLife.23156 · DOI · Paper page
- V Stalls, 2022, Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike, Cell Rep, 39, 111009, 10.1016/j.celrep.2022.111009 · DOI
- Y Cao, 2022, Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75., bioRxiv, 2022
- D Ellis, 2021, Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design., Front Immunol., 12, 710263, 10.3389/fimmu.2021.710263 · DOI
- EC Thomson, 2021, Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity, Cell, 184, 1171, 10.1016/j.cell.2021.01.037 · DOI · Paper page
- AS Gonzalez-Reiche, 2022, Intrahost evolution and forward transmission of a novel SARS-CoV-2 Omicron BA.1 subvariant., medRxiv
- P Shah, 2015, Contingency and entrenchment in protein evolution under purifying selection, Proc Natl Acad Sci U S A, 112, E3226, 10.1073/pnas.1412933112 · DOI · Paper page
- TN Starr, 2018, Pervasive contingency and entrenchment in a billion years of Hsp90 evolution, Proc Natl Acad Sci U S A, 115, 4453, 10.1073/pnas.1718133115 · DOI
- AJ Greaney, 2021, An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain., bioRxiv
- Q Wang, 2022, Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5, Nature, 608, 603, 10.1038/s41586-022-05053-w · DOI · Paper page
- Y Cao, 2022, BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection, Nature, 608, 593, 10.1038/s41586-022-04980-y · DOI · Paper page
- LI Gong, 2013, Stability-mediated epistasis constrains the evolution of an influenza protein, Elife, 2, e00631, 10.7554/eLife.00631 · DOI · Paper page
- K Westendorf, 2022, LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants., Cell Rep, 39, 110812, 10.1016/j.celrep.2022.110812 · DOI · Paper page
- DS Smyth, 2022, Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater., Nat Commun, 13, 635, 10.1038/s41467-022-28246-3 · DOI · Paper page
- DA Gregory, 2022, Genetic Diversity and Evolutionary Convergence of Cryptic SARS-CoV-2 Lineages Detected Via Wastewater Sequencing., medRxiv
- Y Cao, 2022, Imprinted SARS-CoV-2 humoral immunity induces converging Omicron RBD evolution., bioRxiv, 2022
- Y-J Park, 2022, Imprinted antibody responses against SARS-CoV-2 Omicron sublineages., bioRxiv, 2022
- L Witte, 2022, Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape., bioRxiv
- TN Starr, 2021, SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape, Nature
- Y-J Park, 2022, Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry, Science, 375, 449, 10.1126/science.abm8143 · DOI
- AJ Greaney, 2022, A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy., PLoS Pathog., 18, e1010248, 10.1371/journal.ppat.1010248 · DOI
- AE Wentz, 2007, A novel high-throughput screen reveals yeast genes that increase secretion of heterologous proteins, Appl Environ Microbiol, 73, 1189, 10.1128/AEM.02427-06 · DOI
- RD Gietz, 2007, Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method, Nat Protoc, 2, 38, 10.1038/nprot.2007.15 · DOI · Paper page
- KHD Crawford, 2019, alignparse: A Python package for parsing complex features from high-throughput long-read sequencing., J Open Source Softw., 4
- N Peterman, 2016, Sort-seq under the hood: implications of design choices on large-scale characterization of sequence-function relations, BMC Genomics, 17, 206, 10.1186/s12864-016-2533-5 · DOI
- M Delignette-Muller, 2015, fitdistrplus: An R Package for Fitting Distributions, Journal of Statistical Software, Articles., 64, 1
Cited by
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Wang, Q., Iketani, S., Li, Z., Liu, L., Guo, Y., Huang, Y., Bowen, A. D., Liu, M., Wang, M., Yu, J., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.018 · Cited by 912
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
Yue, C., Song, W., Wang, L., Jian, F., Chen, X., Gao, F., Shen, Z., Wang, Y., Wang, X., & Cao, Y. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00010-5 · Cited by 328
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Yisimayi, A., Song, W., Wang, J., Jian, F., Yu, Y., Chen, X., Xu, Y., Yang, S., Niu, X., Xiao, T., et al. (2024) · Nature · doi:10.1038/s41586-023-06753-7 · Cited by 253
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
(2023) · doi:10.1038/s41467-023-43638-9 · Cited by 26
Moriyama, S., Anraku, Y., Taminishi, S., Adachi, Y., Kuroda, D., Kita, S., Higuchi, Y., Kirita, Y., Kotaki, R., Tonouchi, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39890-8 · Cited by 22
Metadata
- Authors
- Starr, T. N., Greaney, A. J., Stewart, C. M., Walls, A. C., Hannon, W. W., Veesler, D., & Bloom, J. D.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-11-18
- Volume
- 18
- Issue
- 11
- Pages
- e1010951
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W4309306331
- Cited by
- 192
- References
- 5
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Institute of Allergy and Infectious Diseases (75N93022C00036, 75N93021C00015, K99AI166250, T32AI083203, DP1AI158186, R01AI141707)
- National Institute of General Medical Sciences (R01GM120553)
- Bill and Melinda Gates Foundation (OPP1156262, INV-004949)
- Pew Charitable Trusts (Biomedical Scholars Award)
- Burroughs Wellcome Fund (Investigator in the Pathogenesis of Infectious Disease)
- Fast Grants
- Damon Runyon Cancer Research Foundation (DRG-2381-19)
- Howard Hughes Medical Institute (Investigator)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains. https://app.cochat.ai/papers/10.1371/journal.ppat.1010951
- The paper
- Starr, T. N., Greaney, A. J., Stewart, C. M., Walls, A. C., Hannon, W. W., Veesler, D., & Bloom, J. D. (2022). Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1010951
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
